UiPath PATH Stock Slumps As Traders Question AI Growth Story

UiPath Inc. stocks have been trading down by -3.87 percent amid bearish sentiment over automation demand and growth prospects.

Live Update At 16:47:33 EDT: On Wednesday, September 16, 2026 UiPath Inc. stock [NYSE: PATH] is trending down by -3.87%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

PATH is trading like a stock that just fell off a cliff and is trying to find a new floor. Over the past few weeks, UiPath slid from the high‑$18s down to the mid‑$13s, a drawdown of roughly 25%. That’s a big move for a $B‑plus software name in such a short window.

The daily chart shows PATH breaking down from the $18 area at the end of 2026/08 and failing to bounce meaningfully after earnings. Each attempt to reclaim $15 has been rejected, leaving the stock stuck in a lower range around $13–$14. For active trading, that’s a clear sign sellers are still in control.

Intraday, PATH has been grinding sideways, with narrow 5‑minute candles clustering around $13.60–$13.90. That tells traders volatility is cooling after the initial earnings shock, but there’s no aggressive dip‑buying yet.

Fundamentally, UiPath posted quarterly revenue of about $410M with strong 83% gross margins and positive operating income. Free cash flow of roughly $29M and a current ratio near 2.3 show PATH is not in financial distress. But with a price‑to‑sales ratio around 4.6 and a P/E in the mid‑20s, the market is now questioning how much future AI growth it should still price into PATH.

Why Traders Are Watching PATH After The Selloff

The PATH chart and the news flow are finally in sync, and not in a good way. UiPath dropped 16%–17% after its latest quarterly release, an 11% hit in early trading alone, as traders reacted to what looks like a reset of the AI automation narrative. When a widely watched AI name gaps down that hard, it becomes a prime trading vehicle.

UiPath’s fundamentals were not a disaster. Revenue grew, margins improved modestly, and PATH stayed free‑cash‑flow positive. But Wall Street wanted acceleration, not just stability. BofA’s move tells the story: the bank lifted its price target from $13 to $15, yet still labeled PATH Underperform. That’s like saying, “We see a little upside from here, but we think you can do better elsewhere.”

For traders, the real sting is around AI expectations. BofA is openly questioning whether AI will truly speed up UiPath’s annual recurring revenue in the near term. At the same time, RBC is calling out UiPath as part of an application‑software group that is lagging while AI budgets flow to cyber, data, and infrastructure players. That puts PATH on the wrong side of the current capital rotation.

Then there’s the insider angle. CEO Daniel Dines sold about 1.4 million PATH shares, taking in roughly $22.5M. He still controls around 26.5M Class A shares, so he clearly remains heavily tied to UiPath’s future. But traders know sizable insider sales coming right after a rocky quarter rarely help sentiment. Add all this up and PATH turns into a classic “fallen AI favorite” setup: heavy gap down, skeptical analysts, and a crowd trying to figure out if this is just a reset or the start of a longer slide.

Conclusion

For active traders, PATH now lives in a very different neighborhood than it did a few weeks ago. UiPath has gone from a steady AI automation story to a name fighting to defend its premium while the broader market rotates toward other corners of the AI stack. The 16%–17% post‑earnings drop, followed by weeks stuck in the mid‑$13s, shows that many are waiting on the sidelines rather than rushing back in.

Yet volatility is opportunity for disciplined day traders and swing traders. PATH still has strong gross margins, positive cash flow, and a fortress‑like balance sheet, but the crowd is questioning growth and sector positioning. That tension between solid fundamentals and shaken confidence can drive powerful reaction moves around news, upgrades, or any hint that AI‑driven ARR is re‑accelerating.

The key is to respect the price action, not the story. UiPath is now a “show me” stock. Until the chart proves the downtrend is over, every bounce is suspect and every breakdown can snowball. As millionaire penny stock trader and teacher Tim Sykes, says, “Preparation plus patience leads to big profits.”. As Tim Sykes likes to say, “The market doesn’t care about your opinion, only your discipline — cut losses quickly and let the best setups come to you.” For PATH, that means watching support, volume, and catalysts like a hawk, and trading the range — not the hype.

This article is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

• Penny Stocks Trading Guide
• Best Penny Stocks Under $1 to Buy Today
• Top 8 Penny Stocks to Watch on Robinhood

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks